McIlrath & Eck’s Repligen RGEN Stock Holding History

McIlrath & Eck’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.12K	Hold	35	–	–	﹤0.01%	1257
2025 Q4	$5.74K	Hold	35	–	–	﹤0.01%	755
2025 Q3	$4.68K	Hold	35	–	–	﹤0.01%	756
2025 Q2	$4.35K	Hold	35	–	–	﹤0.01%	740
2025 Q1	$4.45K	Hold	35	–	–	﹤0.01%	742
2024 Q4	$5.04K	Hold	35	–	–	﹤0.01%	754
2024 Q3	$5.21K	Hold	35	–	–	﹤0.01%	739
2024 Q2	$4.41K	Hold	35	–	–	﹤0.01%	735
2024 Q1	$6.44K	Hold	35	–	–	﹤0.01%	680
2023 Q4	$6.29K	Hold	35	–	–	﹤0.01%	635
2023 Q3	$5.57K	Hold	35	–	–	﹤0.01%	633
2023 Q2	$4.95K	Hold	35	–	–	﹤0.01%	674
2023 Q1	$5.89K	Hold	35	–	–	﹤0.01%	635
2022 Q4	$5.93K	Hold	35	–	–	﹤0.01%	608
2022 Q3	$7K	Hold	35	–	–	﹤0.01%	591
2022 Q2	$6K	Hold	35	–	–	﹤0.01%	594
2022 Q1	$7K	Hold	35	–	–	﹤0.01%	589
2021 Q4	$9K	Hold	35	–	–	﹤0.01%	551
2021 Q3	$10K	Hold	35	–	–	﹤0.01%	526
2021 Q2	$7K	Hold	35	–	–	﹤0.01%	582
2021 Q1	$7K	Buy	+35	New	+$7.18K	﹤0.01%	543

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

McIlrath & Eck's RGEN Position: Q1 2026 in Review

McIlrath & Eck held its Repligen (RGEN) position steady in Q1 2026 at 35 shares worth $4.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1257.

McIlrath & Eck first reported a position in RGEN in Q1 2021 and has held it in 21 quarters since. The position peaked at $10K in Q3 2021. 445 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

McIlrath & Eck held 35 shares of Repligen worth $4.12K as of Q1 2026.
McIlrath & Eck left its Repligen share count unchanged in Q1 2026.
Repligen made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1257 holding.
McIlrath & Eck first reported a position in Repligen in Q1 2021 and has held it in 21 quarters since.
McIlrath & Eck's Repligen position peaked at $10K in Q3 2021.
445 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.